S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

PDS Biotechnology Corporation Common Stock

PDSB XNAS
$0.55 +0.02 (+3.42%) ▲ 15-min delayed
Open
$0.58
High
$0.60
Low
$0.54
Volume
589.2K
Market Cap
$31.22M

About PDS Biotechnology Corporation Common Stock

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 24 Website →

Key Financials

Period Revenue Net Income EPS
Q3 2025 $0 $-9,009,411 $-0.19
Q1 2025 $0 $-8,488,967 $-0.21
FY 2024 $0 $-37,610,384 $-1.03
Q3 2024 $0 $-10,726,658 $-0.29

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026
Calendar →

Related Market News

No specific coverage for PDSB yet. Check out our latest market news or earnings calendar.

Get PDSB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on PDS Biotechnology Corporation Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.